Uncategorized

Qualtran Facilitates Hero MotoCorp-EBR Strategic Partnership Qualtran Facilitates Hero MotoCorp-EBR Strategic Partnership Hero MotoCorp ties up with EBR to bring next-generation high-end bikes to India and augment its R&D capabilities CLEVELAND, Feb. 28, 2012 Hero MotoCorp Ltd (HMCL), the world’s largest two-wheeler manufacturer, and the US-based Erik Buell Racing (EBR) last week announced a strategic …

Qualtran Facilitates Hero MotoCorp-EBR Strategic Partnership Read More »

Aethlon Medical Announces FDA Approval of IDE to Treat Hepatitis C (HCV) Patients “Aethlon Medical Announces FDA Approval of IDE to Treat Hepatitis C (HCV) Patients”. Tuesday, 25 Jun 2013 SAN DIEGO, June 25, 2013 /PRNewswire/ — Aethlon Medical, Inc. (OTCQB: AEMD), announced today that the United States Food and Drug Administration (FDA) has approved …

Aethlon Medical Announces FDA Approval of IDE to Treat Hepatitis C (HCV) Patients Read More »

Hero MotoCorp picks up 49.2% stake in US-based Erik Buell Racing for $25 million Hero MotoCorp picks up 49.2% stake in US-based Erik Buell Racing for $25 million Reuters, Hindustan Times, Times of India and FT, Monday, 1 July 2013 NEW DELHI: Cometh the hour, cometh the man! The Pawan Munjal that the media in …

Hero MotoCorp picks up 49.2% stake in US-based Erik Buell Racing for $25 million Read More »

Qualtran Signs an Agreement with Aquagenics Qualtran Signs an Agreement with Aquagenics prlog.com, Tuesday, 29 April 2014 Qualtran signed an agreement with Aquagenics Technologies of Napeville, IL to commercialize some disruptive technologies in India. These technologies include, Aquagenics owned biotech and environmental technologies. The agreement entails licensing, product development and commercialization in India and other …

Qualtran Signs an Agreement with Aquagenics Read More »

Aethlon Medical Announces Dengue Virus Treatment Agreement Aethlon Medical Announces Dengue Virus Treatment Agreement September 24, 2014: 09:30 AM ET SAN DIEGO, Sept. 24, 2014 /PRNewswire/ — Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has entered into …

Aethlon Medical Announces Dengue Virus Treatment Agreement Read More »

Qualtran ties up with Memchan Pharma for detection of cancer cells in blood using Dielectrophoresis Qualtran ties up with Memchan Pharma for detection of cancer cells in blood using Dielectrophoresis July 2017 Memchan Pharma is a venture promoted by Arthur M. “Buzz” Brown, M.D., Ph.D., who established ChanTest Corp. in Ohio in 1998. The company …

Qualtran ties up with Memchan Pharma for detection of cancer cells in blood using Dielectrophoresis Read More »

Qualtran & Vega Building Systems participate in Global Housing Technology Challenge 2018 in India Qualtran & Vega Building Systems participate in Global Housing Technology Challenge 2018 in India September 2018 Global Housing Technology Challenge, GHTC, was announced by Prime Minister Modi with an objective to obtain best available innovative construction technologies from across the globe …

Qualtran & Vega Building Systems participate in Global Housing Technology Challenge 2018 in India Read More »

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier® Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier® SAN DIEGO, June 3, 2021 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today …

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier® Read More »

Corcept, one of the fastest growing companies in US partners with Qualtran for Cortisol research projects in India Corcept, one of the fastest growing companies in US partners with Qualtran for Cortisol research projects in India September 2018 Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. …

Corcept, one of the fastest growing companies in US partners with Qualtran for Cortisol research projects in India Read More »

Qualtran Sign an Agreement with Exhalent Diagnostic to field test COVID-19 & Tuberculosis through breath-based devices Qualtran Sign an Agreement with Exhalent Diagnostic to field test COVID-19 & Tuberculosis through breath-based devices. Ohio, United States 16, Oct 2020. Qualtran signed an agreement with Exhalent Diagnostic of Taylorsville, United States for field testing of devices designed …

Qualtran Sign an Agreement with Exhalent Diagnostic to field test COVID-19 & Tuberculosis through breath-based devices Read More »